Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: Cohort and case-control study

被引:40
作者
Castilla, Jesus [1 ]
Martinez-Artola, Victor [2 ]
Salcedo, Esther [2 ]
Martinez-Baz, Ivan [1 ]
Garcia Cenoz, Manuel [1 ]
Guevara, Marcela [1 ]
Alvarez, Nerea [3 ]
Irisarri, Fatima [1 ]
Moran, Julio [4 ]
Barricarte, Aurelio [1 ]
机构
[1] Inst Salud Publ Navarra, Pamplona 31003, Navarra, Spain
[2] Complejo Hosp Navarra, Pamplona, Spain
[3] Serv Navarro Salud, Direcc Atenc Especializada, Pamplona, Spain
[4] Serv Navarro Salud, Direcc Atenc Primaria, Pamplona, Spain
关键词
Influenza vaccines; Influenza A virus; H1N1; subtype; Cohort studies; Case-control studies; Spain; REDUCED RISK; ASSOCIATION; INFARCTION; EFFICACY; DESIGNS; FIELD;
D O I
10.1016/j.vaccine.2011.11.024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
We evaluated the 2010-2011 seasonal influenza vaccine effectiveness in preventing hospitalizations. Using healthcare databases we defined the target population for vaccination in Navarre, Spain, consisting of 217,320 people with major chronic conditions or aged 60 years and older. All hospitalized patients with influenza-like illness (ILI) were swabbed for influenza testing. A total of 269 patients with ILI were hospitalized and 61 of them were found positive for influenza virus: 58 for A(HIN1)2009 and 3 for B virus. The incidence rates of hospitalization with laboratory-confirmed influenza were compared by vaccination status. In the Cox regression model adjusted for sex, age, children in the household, urban/rural residence, comorbidity, pandemic vaccination, pneumococcal vaccination, outpatient visits and hospitalization in the previous year, the seasonal vaccine effectiveness was 58% (95% CI: 16-79%). The nested test-negative case-control analysis gave an adjusted estimate of 59% (95% CI: 4-83%). These results suggest a moderate effect of the 2010-2011 seasonal influenza vaccine in preventing hospitalization in a risk population. The close estimates obtained in the cohort and the test-negative case-control analyses suggest good control of biases. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:195 / 200
页数:6
相关论文
共 23 条
[1]
[Anonymous], 2010, WKLY EPIDEMIOL REC, V85, P81
[2]
[Anonymous], BMJ
[3]
European Centre for Disease Prevention and Control, 2011, ECDC RISK ASS SEAS I
[4]
SERIOUS MORBIDITY AND MORTALITY ASSOCIATED WITH INFLUENZA EPIDEMICS [J].
GLEZEN, WP .
EPIDEMIOLOGIC REVIEWS, 1982, 4 :25-44
[5]
Quantifying the potential role of unmeasured confounders: the example of influenza vaccination [J].
Groenwold, R. H. H. ;
Hoes, A. W. ;
Nichol, K. L. ;
Hak, E. .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2008, 37 (06) :1422-1429
[6]
Flu vaccination in acute coronary syndromes and planned percutaneous (FLUVACS) study - One-year follow-up [J].
Gurfinkel, EP ;
de la Fuente, RL ;
Mendiz, O ;
Mautner, B .
EUROPEAN HEART JOURNAL, 2004, 25 (01) :25-31
[7]
Using validation sets for outcomes and exposure to infection in vaccine field studies [J].
Halloran, ME ;
Longini, IM .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 154 (05) :391-398
[8]
Institut de Salud Ptiblica de Navarra, 2010, I SAL PUBL NAV B INF, V59
[9]
Evidence of bias in estimates of influenza vaccine effectiveness in seniors [J].
Jackson, LA ;
Jackson, ML ;
Nelson, JC ;
Neuzil, KM ;
Weiss, NS .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2006, 35 (02) :337-344
[10]
Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review [J].
Jefferson, T ;
Rivetti, D ;
Rivetti, A ;
Rudin, M ;
Di Pietrantonj, C ;
Demicheli, V .
LANCET, 2005, 366 (9492) :1165-1174